A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists. British business minister Vince Cable announced the new partnership on Tuesday between the Medical Research Council (MRC) and the companies, under which the researchers will gain access to "deprioritized" pharmaceutical compounds. AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer, Takeda and UCB have all signed up to the scheme, which builds on the success of an earlier two-way program between AstraZeneca and the MRC. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment